Capital expenditure increased 47.7%
Capital expenditure changed +47.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +47.7% from the comparable as-filed period.
Working capital / assets changed +620 basis points from the comparable as-filed period.
Cost of revenue changed +17.9% from the comparable as-filed period.
Capex / revenue changed +64 basis points from the comparable as-filed period.
Operating cash flow / net income changed -12.3% from the comparable as-filed period.
Selling, general & administrative changed +8.0% from the comparable as-filed period.
Operating cash-flow margin changed +118 basis points from the comparable as-filed period.
Receivables / revenue changed -93 basis points from the comparable as-filed period.
Inventory changed +2.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current ratio changed -4.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +54 basis points from the comparable as-filed period.
Capital expenditure changed +79.4% from the comparable as-filed period.
Total assets changed +23.4% from the comparable as-filed period.
Inventory changed +5.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed +686 basis points from the comparable as-filed period.
Capex / revenue changed +213 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1435 basis points from the comparable as-filed period.
Receivables / revenue changed -452 basis points from the comparable as-filed period.
Free-cash-flow margin changed +1221 basis points from the comparable as-filed period.
Operating cash flow / net income changed +18.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed +14.7% from the comparable as-filed period.
Selling, general & administrative changed +8.6% from the comparable as-filed period.
Current ratio changed -4.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.